Todd Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $53.3M | Sell |
421,984
-155,819
| -27% | -$20.5M | 0.95% | 42 |
|
|
2026
Q1 | $80.5M | Sell |
577,803
-5,976
| -1% | -$837K | 1.58% | 8 |
|
|
2025
Q4 | $71.7M | Buy |
583,779
+9,302
| +2% | +$1.13M | 1.4% | 15 |
|
|
2025
Q3 | $63.8M | Sell |
574,477
-22,499
| -4% | -$2.56M | 1.29% | 16 |
|
|
2025
Q2 | $66.2M | Buy |
596,976
+305,980
| +105% | +$32.6M | 1.43% | 11 |
|
|
2025
Q1 | $32.6M | Buy |
290,996
+278,490
| +2,227% | +$28.7M | 0.77% | 60 |
|
|
2024
Q4 | $1.16M | Hold |
12,506
| – | – | 0.03% | 136 |
|
|
2024
Q3 | $1.05M | Hold |
12,506
| – | – | 0.02% | 145 |
|
|
2024
Q2 | $858K | Buy |
12,506
+42
| +0.3% | +$2.8K | 0.02% | 178 |
|
|
2024
Q1 | $913K | Buy |
12,464
+441
| +4% | +$33.9K | 0.02% | 180 |
|
|
2023
Q4 | $974K | Sell |
12,023
-273,340
| -96% | -$21.3M | 0.02% | 179 |
|
|
2023
Q3 | $21.4M | Buy |
285,363
+26,720
| +10% | +$2.06M | 0.51% | 91 |
|
|
2023
Q2 | $19.9M | Buy |
258,643
+243,993
| +1,665% | +$19.5M | 0.46% | 108 |
|
|
2023
Q1 | $1.22M | Buy |
14,650
+97
| +0.7% | +$8.03K | 0.03% | 169 |
|
|
2022
Q4 | $1.25M | Sell |
14,553
-1,689
| -10% | -$134K | 0.03% | 172 |
|
|
2022
Q3 | $1M | Buy |
16,242
+260
| +2% | +$16.4K | 0.03% | 171 |
|
|
2022
Q2 | $988K | Buy |
15,982
+334
| +2% | +$20.7K | 0.03% | 178 |
|
|
2022
Q1 | $930K | Buy |
15,648
+240
| +2% | +$15.3K | 0.02% | 183 |
|
|
2021
Q4 | $1.12M | Hold |
15,408
| – | – | 0.02% | 177 |
|
|
2021
Q3 | $1.08M | Sell |
15,408
-2,177
| -12% | -$153K | 0.02% | 180 |
|
|
2021
Q2 | $1.21M | Sell |
17,585
-3,012
| -15% | -$201K | 0.03% | 178 |
|
|
2021
Q1 | $1.33M | Buy |
+20,597
| New | +$1.33M | 0.03% | 175 |
|
|
2018
Q3 | – | Sell |
-248,883
| Closed | -$17.6M | – | 219 |
|
|
2018
Q2 | $17.6M | Sell |
248,883
-2,819
| -1% | -$199K | 0.5% | 85 |
|
|
2018
Q1 | $19M | Sell |
251,702
-16,913
| -6% | -$1.34M | 0.52% | 80 |
|
|
2017
Q4 | $19.2M | Buy |
268,615
+57,341
| +27% | +$4.35M | 0.52% | 81 |
|
|
2017
Q3 | $17.1M | Buy |
+211,274
| New | +$16.2M | 0.47% | 93 |
|
|
2017
Q1 | – | Sell |
-175,287
| Closed | -$12.6M | – | 215 |
|
|
2016
Q4 | $12.6M | Buy |
+175,287
| New | +$13M | 0.38% | 120 |
|
|
2016
Q3 | – | Sell |
-407,301
| Closed | -$34M | – | 213 |
|
|
2016
Q2 | $34M | Sell |
407,301
-215,596
| -35% | -$19.1M | 1.08% | 20 |
|
|
2016
Q1 | $57.2M | Buy |
622,897
+91,052
| +17% | +$8.21M | 1.7% | 4 |
|
|
2015
Q4 | $53.8M | Sell |
531,845
-118,229
| -18% | -$12.3M | 1.63% | 9 |
|
|
2015
Q3 | $63.8M | Sell |
650,074
-37,846
| -6% | -$4.2M | 2% | 5 |
|
|
2015
Q2 | $80.5M | Buy |
687,920
+56,257
| +9% | +$6.15M | 2.19% | 3 |
|
|
2015
Q1 | $62M | Sell |
631,663
-104,865
| -14% | -$10.6M | 1.73% | 9 |
|
|
2014
Q4 | $69.4M | Buy |
736,528
+112,493
| +18% | +$11.6M | 1.93% | 4 |
|
|
2014
Q3 | $66.4M | Buy |
624,035
+353,082
| +130% | +$34.6M | 1.9% | 3 |
|
|
2014
Q2 | $22.5M | Buy |
+270,953
| New | +$21.1M | 0.64% | 50 |
|
|
2013
Q3 | – | Sell |
-41,200
| Closed | -$2.11M | – | 218 |
|
|
2013
Q2 | $2.11M | Buy |
+41,200
| New | +$2.15M | 0.07% | 169 |
|
Other funds holding GILD
Todd Asset Management's GILD Position: Q2 2026 in Review
Todd Asset Management reduced its Gilead Sciences (GILD) stake by 27% in Q2 2026, selling an estimated $20.5M and leaving 421,984 shares worth $53.3M. The position accounts for 0.95% of the portfolio, ranked #42.
Todd Asset Management first reported a position in GILD in Q2 2013 and has held it in 37 quarters since. The position peaked at $80.5M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Todd Asset Management held 421,984 shares of Gilead Sciences worth $53.3M as of Q2 2026.
- Todd Asset Management sold 155,819 Gilead Sciences shares in Q2 2026, an estimated $20.5M.
- Gilead Sciences made up 0.95% of Todd Asset Management's portfolio in Q2 2026, its #42 holding.
- Todd Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 37 quarters since.
- Todd Asset Management's Gilead Sciences position peaked at $80.5M in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Todd Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.